Divi's Laboratories Limited has submitted a regulatory filing to the National Stock Exchange of India Limited and BSE Limited regarding the earnings conference call for the second quarter of fiscal year 2027.
The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This submission follows a previous intimation letter dated November 02, 2026 regarding the same earnings call.
The company held its Q2 FY27 earnings conference call on November 07, 2026 at 14:00 hours IST. The call covered financial results for the quarter and half year ended September 30, 2026.
The audio recording of this earnings call has been uploaded to the company's official website and is available in the Investor Relations section. The specific web link provided is: https://www.divislabs.com/wp-content/uploads/2026/11/Q2FY27-earnings-call-07.11.2026.webm
The document was signed by M. Satish Choudhury, who holds the positions of Company Secretary and Compliance Officer at Divi's Laboratories Limited. The digital signature timestamp shows the document was executed on November 07, 2026 at 17:01:17 IST.